These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 22388840)
1. [Adacolumn apheresis for hepatitis C virus in patients waiting for kidney transplant. Preliminary study]. Novelli G; Ferretti G; Morabito V; Cinti P; Poli L; Pretagostini R; Berloco PB G Ital Nefrol; 2012; 29 Suppl 54():S109-13. PubMed ID: 22388840 [TBL] [Abstract][Full Text] [Related]
2. Adacolumn treatment in kidney transplant patients with hepatitis C virus. Novelli G; Rossi M; Ferretti G; Poli L; Pretagostini R; Ruberto F; Morabito V; Cinti P; Nudo F; Mennini G; Berloco PB Transplant Proc; 2009 May; 41(4):1195-200. PubMed ID: 19460515 [TBL] [Abstract][Full Text] [Related]
3. Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis. Novelli G; Rossi M; Morabito V; Ferretti G; Pretagostini R; Ruberto F; Pugliese F; Guglielmo N; Berloco PB Transplant Proc; 2012 Sep; 44(7):1946-52. PubMed ID: 22974879 [TBL] [Abstract][Full Text] [Related]
4. Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C. Moriyama M; Kaneko M; Matsumura H; Fukushima A; Aoki H; Tanaka N; Kuroda K; Shimizu K; Hiraishi K; Arakawa Y Intervirology; 2005; 48(2-3):84-8. PubMed ID: 15812179 [TBL] [Abstract][Full Text] [Related]
5. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects. Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Kanke K; Nakano M; Hiraishi H; Terano A Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166 [TBL] [Abstract][Full Text] [Related]
10. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314 [TBL] [Abstract][Full Text] [Related]
11. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients]. Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of hepatitis C infection after liver transplantation. Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients. Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548 [TBL] [Abstract][Full Text] [Related]
15. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502 [TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C virus infection in patients with end-stage renal disease. Liu CH; Kao JH J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711 [TBL] [Abstract][Full Text] [Related]
17. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C. Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
19. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452 [TBL] [Abstract][Full Text] [Related]
20. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]